logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hai-Qiang Mai

Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
H指数:28
被引数:3,226

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trial

同步放化疗联合尼莫单抗 versus 放化疗单用治疗对诱导化疗反应欠佳的局部晚期鼻咽癌：一项随机Ⅱ期试验

Nature Communications
IF15.7
2026-03-310
OAAI
Li-Ting Liu; Xue-Song Sun; Ting-Ting Quan; Xiao-Yun Li; Ling Guo; Hao-Yuan Mo; Shan-Shan Guo; Sai-Lan Liu; Ying Huang; Dong-Hua Luo; Rui Sun; Guo-Dong Jia; Ji-Bin Li; Qing Liu; Pan Wang; Yu-Jing Liang; Jie Chen; Yi-Fu Li; Hui Cheng; Wei-Xiong Xia; Fang Qiu; Jin-Hao Yang; Qi Yang; Dong-Xiang Wen; Jin-Jie Yan; Chong Zhao; Qiu-Yan Chen; Lin-Quan Tang; Hai-Qiang Mai
[18F] Fluorodeoxyglucose positron emission tomography/computed tomography scan and liquid biopsy at 12 weeks posttreatment for surveillance of locoregionally advanced nasopharyngeal carcinoma

[18F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描检查及液体活检，于治疗后12周进行，用于监测局部晚期鼻咽癌。

European Journal of Nuclear Medicine and Molecular Imaging
IF7.6
2025-10-010
PRE
Li-Ting Liu; Zhen-Chong Yang; Jia-Rui He; Hao-Xiang Long; Ying-Ying Hu; Jia-Yi Shen; Mei-Juan Luo; Yu-Chen Li; Xu Zhang; Su-Chen Li; Zi-Jian Lu; Bei-Bei Xiao; Jin-Hao Yang; Xiao-Fei Lv; Yu-Jing Liang; Shan-Shan Guo; Sai-Lan Liu; Xue-Song Sun; Xiao-Yun Li; Li Yuan; Liang-Ji Li; Guo-Dong Jia; Xue-Bin Xie; Kuok-Wai IU; Wei Fan; Qiu-Yan Chen; Melvin L. K. Chua; Hai-Qiang Mai; Lin-Quan Tang
Locoregional Radiotherapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: Real-World Insights in the Immunotherapy Era

局部区域放射治疗候选者在原发转移性鼻咽癌中的应用：免疫治疗时代的真实世界洞察

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2025-04-010
PRE
Wen, Dongxiang; Jin, Jing; Lin, Jieyi; Luo, Meijuan; Liu, Rongping; Liu, Siqi; Xiong, Longbin; Liu, Liting; Tang, Linquan; Mai, Haiqiang; Guo, Shanshan; Liang, Yujing; Chen, Qiuyan
A prognostic and predictive model based on deep learning to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma: A retrospective multicenter study

基于深度学习的预后和预测模型，用于识别鼻咽癌II期患者单纯调强放疗的适宜候选者：一项回顾性多中心研究

RADIOTHERAPY AND ONCOLOGY
IF5.3
2025-02-010
PRE
Liang, Jiong-Lin; Wen, Yue-Feng; Huang, Ying-Ping; Guo, Jia; He, Yun; Xing, Hong-Wei; Guo, Ling; Mai, Hai-Qiang; Yang, Qi
Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma

单细胞和空间转录组分析揭示了与鼻咽癌肿瘤进展和免疫治疗反应相关的三级淋巴样结构

NATURE COMMUNICATIONS
IF15.7
2024-09-043
OAAI
Liu, Yang; Ye, Shuang-Yan; He, Shuai; Chi, Dong-Mei; Wang, Xiu-Zhi; Wen, Yue-Feng; Ma, Dong; Nie, Run-Cong; Xiang, Pu; Zhou, You; Ruan, Zhao-Hui; Peng, Rou-Jun; Luo, Chun-Ling; Wei, Pan-Pan; Lin, Guo-Wang; Zheng, Jian; Cui, Qian; Cai, Mu-Yan; Yun, Jing-Ping; Dong, Junchao; Mai, Hai-Qiang; Xia, Xiaojun; Bei, Jin-Xin
Original Research Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
EUROPEAN JOURNAL OF CANCER
IF7.1
2023-11-016
PRE
Guo, Shan -Shan; Yang, Jin-Hao; Sun, Xue-Song; Liu, Li-Zhi; Yang, Zhen-Chong; Liu, Li -Ting; Liu, Sai-Lan; Li, Xiao-Yun; Lv, Xiao-Fei; Luo, Dong-Hua; Li, Ji-Bin; Liu, Qing; Wang, Pan; Guo, Ling; Mo, Hao-Yuan; Sun, Rui; Yang, Qi; Liang, Yu-Jing; Jia, Guo-Dong; Zhao, Chong; Chen, Qiu-Yan; Tang, Lin-Quan; Mai, Hai-Qiang
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients
EUROPEAN JOURNAL OF CANCER
IF7.1
2023-09-017
PRE
Liang, Yu-Jing; Chen, Qiu-Yan; Xu, Jing-Xiao; Liu, Xiu-Feng; Xia, Jian-Chuan; Liu, Li-Ting; Guo, Shan-Shan; Song, Bin; Wang, Pan; Li, Ji-Bin; Liu, Qing; Mo, Hao-Yuan; Guo, Ling; Sun, Rui; Luo, Dong-Hua; He, Jia; Liu, Yi-Na; Nie, Cai-Ping; Tang, Lin-Quan; Li, Jiang; Mai, Hai-Qiang
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial

Camrelizumab联合阿帕替尼治疗一线铂类耐药或PD-1抑制剂耐药复发/转移性鼻咽癌的单臂2期临床试验

NATURE COMMUNICATIONS
IF15.7
2023-08-1413
OAAI
Yuan, Li; Jia, Guo-Dong; Lv, Xiao-Fei; Xie, Si-Yi; Guo, Shan-Shan; Lin, Da-Feng; Liu, Li-Ting; Luo, Dong-Hua; Li, Yi-Fu; Deng, Shen-Wen; Guo, Ling; Zeng, Mu-Sheng; Cai, Xiu-Yu; Liu, Sai-Lan; Sun, Xue-Song; Li, Xiao-Yun; Li, Su-Chen; Chen, Qiu-Yan; Tang, Lin-Quan; Mai, Hai-Qiang

研究方向

暂未获取到该数据
L
Lin‐Quan Tang
H 指数:32论文数:176被引数:3,905
Q
Qiuyan Chen
H 指数:44论文数:339被引数:7,012
L
Li‐Ting Liu
H 指数:23论文数:160被引数:2,003
L
Ling Guo
H 指数:47论文数:262被引数:8,406
S
Shanshan Guo
H 指数:31论文数:258被引数:4,198
Y
Yuan Li
H 指数:18论文数:62被引数:1,033
G
Guo-Dong Jia
H 指数:8论文数:22被引数:397
罗
罗东华
H 指数:22论文数:123被引数:1,536
S
Sai‐Lan Liu
H 指数:18论文数:116被引数:1,231
C
Chong Zhao
H 指数:52论文数:380被引数:1.0万